GLP-1RAs protective against dementia, stroke in people with T2D, obesity
28 Jul 2025
bởiJairia Dela Cruz
For adults with type 2 diabetes (T2D) and obesity, the use of glucagon-like peptide 1 receptor agonists (GLP-1RAs) semaglutide and tirzepatide provides substantial protection against dementia, stroke, and death, according to a large retrospective cohort study.
GLP-1RAs protective against dementia, stroke in people with T2D, obesity
28 Jul 2025